Bernardo F. Sanchez-Dalmau

Hospital Clínic de Barcelona
Country flagSpain

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Background Microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) are the two major antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV). Objectives To characterize a homogenous AAV cohort and to assess the impact of clinicopathological profiles and ANCA serotypes on clinical presentation and prognosis. Clinical differences in GPA patients according to ANCA serotype and the diagnostic yield for vasculitis of biopsies in different territories were also investigated. Results This retrospective study (2000–2021) included 152 patients with AAV (77 MPA/75 GPA). MPA patients (96.1% myeloperoxidase [MPO]–ANCA and 2.6% proteinase 3 [PR3]–ANCA) presented more often with weight loss, myalgia, renal involvement, interstitial lung disease (ILD), cutaneous purpura, and peripheral nerve involvement. Patients with GPA (44% PR3–ANCA, 33.3% MPO, and 22.7% negative/atypical ANCA) presented more commonly with ear, nose, and throat and eye/orbital manifestations, more relapses, and higher survival than patients with MPA. GPA was the only independent risk factor for relapse. Poor survival predictors were older age at diagnosis and peripheral nerve involvement. ANCA serotypes differentiated clinical features in a lesser degree than clinical phenotypes. A mean of 1.5 biopsies were performed in 93.4% of patients in different territories. Overall, vasculitis was identified in 80.3% (97.3% in MPA and 61.8% in GPA) of patients. Conclusions The identification of GPA presentations associated with MPO–ANCA and awareness of risk factors for relapse and mortality are important to guide proper therapeutic strategies in AAV patients. Biopsies of different affected territories should be pursued in difficult‐to‐diagnose patients based on their significant diagnostic yield.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (14)

Nasrin Asgari

Professor

University of Southern Denmark

DENMARK
View details

Zsolt Illes

Professor

-

DENMARK
View details

Elias S Sotirchos

Johns Hopkins University

UNITED STATES
View details

Philipp Albrecht

-

GERMANY
View details

Axel Petzold

UCL Institute of Neurology, University College London

UNITED KINGDOM
View details

Alvaro Jose Mejia-Vergara

University of Florida

UNITED STATES
View details

Sara Samadzadeh

University of Düsseldorf

GERMANY
View details

Frank Konietschke

-

GERMANY
View details

Benjamin Knier

Technical University of Munich

GERMANY
View details

Maria do Carmo Pereira da Costa

Assistant Professor

University of Michigan

UNITED STATES
View details

Adriana Garcia-Herrera

Adjunct medical lecturer

University of Barcelona

SPAIN
View details

Friedemann Paul

-

GERMANY
View details

José Hernández‐Rodríguez

-

SPAIN
View details

Pablo Villoslada

Chairman - Professor

Universitat Pompeu Fabra - Campus del Mar

SPAIN
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.